[P-292] Effects of Nusinersen for spinal muscular atrophy type 1 and type 2 less than 3—years of age
Takenori Tozawa1, TOMOHIRO CHIYONOBU1, TATSUJI HASEGAWA1, MICHIKO YOSHIDA1, AKARI TAKAI1, SATOSHI SAKAUE1, YUI ZEN1, TAKASHI MORITA2, MASAFUMI MORIMOTO1 (1.Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Kyoto chubu medical center, Nantan, Japan)